Alpha DNA Investment Management’s Tilray TLRY Stock Holding History
Bought
Maintained
Sold
Other funds holding TLRY
EMG
AI
Alpha DNA Investment Management's TLRY Position: Q2 2021 in Review
Alpha DNA Investment Management sold out of Tilray (TLRY) in Q2 2021, closing a stake of 13 shares — an estimated $2K sold.
Alpha DNA Investment Management first reported a position in TLRY in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 356 funds tracked by Wall St. Rank hold TLRY as of Q2 2021.
- Alpha DNA Investment Management reported no remaining Tilray position as of Q2 2021 after selling out during the quarter.
- Alpha DNA Investment Management sold 13 Tilray shares in Q2 2021, an estimated $2K.
- Alpha DNA Investment Management first reported a position in Tilray in Q1 2021 and held it in 1 quarter.
- Alpha DNA Investment Management's Tilray position peaked at $2K in Q1 2021.
- 356 funds tracked by Wall St. Rank held Tilray as of Q2 2021.
Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.